Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 22 | 24 | 21 | 20 | 22 |
| Accounts receivable | -25 | 3 | 28 | 51 | -19 |
| Accounts payable and accrued liabilities | 265 | 105 | -163 | N/A | N/A |
| Other Working Capital | 313 | 108 | -102 | 81 | -64 |
| Other Operating Activity | -1,252 | -1,034 | -872 | -976 | -676 |
| Operating Cash Flow | $-677 | $-794 | $-1,088 | $-824 | $-737 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11 | -28 | -4 | -8 | -11 |
| Other Investing Activity | -1,803 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,814 | $-28 | $-4 | $-8 | $-11 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,715 | 6,488 | 547 | 4,591 | 2,352 |
| Other Financing Activity | -453 | -143 | 0 | -650 | -82 |
| Financing Cash Flow | $1,262 | $6,345 | $547 | $3,940 | $2,270 |
| Beginning Cash Position | 10,313 | 4,863 | 5,407 | 2,049 | 527 |
| End Cash Position | 8,944 | 10,313 | 4,863 | 5,158 | 2,049 |
| Net Cash Flow | $-1,229 | $5,523 | $-544 | $3,107 | $1,521 |
| Free Cash Flow | |||||
| Operating Cash Flow | -677 | -794 | -1,088 | -824 | -737 |
| Capital Expenditure | -11 | -28 | -4 | -8 | N/A |
| Free Cash Flow | -688 | -822 | -1,091 | -833 | -737 |